Il futuro dell'imaging molecolare è personale
Colleghiamo tutte le fasi della Medicina Molecolare
Ricerca
Diagnosi
Terapia
![GEHC MI Landing Page Updates PET-CT Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-ct-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=3D2E235EC799B8AE3EF151AA810B8C97)
PET/TC
Prodotti PET/TC
![GEHC MI Landing Page Updates PET-CT Image 7](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-ct-image-7.jpg?h=640&iar=0&w=1920&rev=-1&hash=20D63E14AC2A711222910D182359B971)
![GEHC MI Landing Page Updates Nuclear Medicine Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-nuclear-medicine-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=70EE8F4BA6617BE2BC120E40B648A857)
Prodotti di medicina nucleare
![GEHC MI Landing Page Updates Nuclear Medicine Image 10](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-nuclear-medicine-image-10.jpg?h=640&iar=0&w=1920&rev=-1&hash=B422258C15A4383DF21BB32B38A9A0AF)
![GEHC MI Landing Page Updates PET Radiopharmacy Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-radiopharmacy-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=BBAC8BF98CDAAEEA61A3BFCA88056C00)
Radiofarmacia PET
Total Gallium. Su richiesta.
Prodotti per la radiofarmacia PET
![GEHC MI Landing Page Updates MI Digital Solutions Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-mi-digital-solutions-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=A80EBDCB100308445CF57DCE8D5BE6C4)
Soluzioni digitali per l'imaging molecolare
Soluzioni digitali per l'imaging molecolare
![GEHC MI Landing Page Updates Smart Subscription Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-smart-subscription-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=8126F29BA1E3C53189A68CF01FACF78A)
Smart Subscription
- Continuo perfezionamento dei sistemi di Imaging Molecolare
- Funzionalità equiparabili in tutte le sedi
- Formazione del personale e operatività facilitate
Prodotti collegati
1. I radiofarmaci potrebbero non essere approvati dai ministri della salute in tutte le regioni.
2. Fonte: Statistiche globali sul cancro 2020: https://doi.org/10.3322/caac.21660